Doha: Saudi rider Khaled Al Hadi guided Doremi du Flot Z to victory in the Small Tour 115 cm class as the ninth round of the ...
Atria Investments Inc lifted its holdings in iShares Floating Rate Bond ETF (BATS:FLOT – Free Report) by 53.7% during the ...
GlobalData on MSN9d
AstraZeneca reports positive outcomes from trial of ImfinziAstraZeneca has reported positive “high-level” outcomes from the randomised Phase III MATTERHORN trial of Imfinzi (durvalumab ...
MATTERHORN is the first global phase 3 trial to show improved event-free survival with an immunotherapy combo vs standard ...
Topline results were announced from a phase 3 trial evaluating durvalumab in combination with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) ...
Saudi rider Khaled al-Hadi guided Doremi du Flot Z to victory in the Small Tour – 115cm class during the ninth round of the ...
FRA offers 11.64% yield but invests in riskier, floating-rate securities, making it vulnerable to interest rate cuts. Check ...
AstraZeneca Plc (NASDAQ:AZN) released high-level results from the MATTERHORN Phase 3 trial evaluating Imfinzi (durvalumab) as ...
Imfinzi is one of AstraZeneca’s key growth drivers for 2025, with potential approvals in stomach and bladder cancers. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback